The Biggest Surprise in the Latest Zika Vaccine: It Works!
On Tuesday, the Centers for Disease Control and Prevention (CDC) released a second set of data on how the Zika vaccine is working.
The data, which was published by the American Society of Microbiology (ASMB), revealed that the vaccine has already been proven effective in preventing birth defects, including microcephaly and microceminomas.
It’s the first time in the history of the vaccine that the number of births have been reduced, although this is still only in a preliminary phase.
The new data, though, shows that the vaccines efficacy has increased, too.
The data comes after a massive surge of the virus hit the United States in March, with cases of microcepaly and babies with microcema being born at a rate of more than 3,000 a day.
Since then, a large number of American cities have had to quarantine their residents.
Many of the cities have gone further, limiting public gatherings and limiting food deliveries.
Many states have also passed legislation banning the travel of people with symptoms of the disease, including severe fever and vomiting.
In an effort to combat the Zika virus, the CDC is also conducting tests on pregnant women.
The tests are being conducted in the hope that the test can detect a genetic condition in the fetus, which would then be passed to the fetus.
That way, the vaccine can be administered in the womb.
The virus is transmitted by the Aedes aegypti mosquito, which is the most common vector for Zika.
It spreads by sexual contact and is usually not transmitted through air.
It is believed that the virus has spread more quickly in the U.S. than anywhere else in the world.
The CDC said the tests are taking place in the states of Arizona, Florida, Indiana, Missouri, North Carolina, Tennessee, Texas, Virginia, and Washington.